Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Almirall ( (ES:ALM) ) has issued an update.
Almirall has completed a capital increase as part of its flexible dividend system, resulting in the issuance of 1,316,480 new shares. This move reflects a strategic effort to enhance shareholder value and strengthen its market position, with the new shares expected to begin trading on major Spanish stock exchanges by June 11, 2025.
The most recent analyst rating on (ES:ALM) stock is a Buy with a EUR17.00 price target. To see the full list of analyst forecasts on Almirall stock, see the ES:ALM Stock Forecast page.
More about Almirall
Almirall, S.A. is a pharmaceutical company that operates in the healthcare industry, focusing primarily on the development and commercialization of dermatological treatments. The company is known for its innovative solutions in skin health and is a key player in the European market.
Average Trading Volume: 145,123
Technical Sentiment Signal: Buy
Current Market Cap: €2.36B
For detailed information about ALM stock, go to TipRanks’ Stock Analysis page.